뒤로
Antengene Corporation Limited(06996.HK) 가격
06996.HK 주가 차트
ANTENGENE-B (06996.HK)
Antengene Corporation Limited
HK$0
0%
$0
장 종료: Jan 29, 16:00:00 HKT
주요 통계
이전 종가
--
시가
--
일일 범위
-
52주 범위
-
거래량
--
평균 거래량
2.4M
EPS(TTM)
-0.40
배당수익률
--
시가총액
--
ANTENGENE-B란 무엇인가요?
Antengene Corp. Ltd. operates as a clinical-stage Asia-Pacific biopharmaceutical company. The company is headquartered in Shanghai, Shanghai and currently employs 152 full-time employees. The company went IPO on 2020-11-20. The firm is principally engaged in the discovery, development, manufacturing and commercialization of biotech products. The firm's products include ATG-010 (selinexor), treating for relapsed/refractory multiple myeloma, relapsed/refractory diffuse large B-cell lymphoma and non-small cell lung cancer and ATG-008 (onatasertib), treating for hepatocellular carcinoma and non-small cell lung cancer. The firm mainly conducts its business in Asia-Pacific.